Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal - The Wall Street Journal

Gilead to Boost Stake in Belgian Biotech Galapagos as Part of $5.1 Billion Deal  The Wall Street Journal

Gilead Sciences will pay $5.1 billion to lift its stake in Galapagos NV and gain rights outside Europe to the Belgian biotechnology company's treatments in ...

View full coverage on Google News
by via Top stories - Google News